P
Market Data
$5.49+$0.89 (+19.35%)
PRLD · Last trade
Prev Close
$4.60
Range (29d)
$4.39 – $6.63
Recent Filings
- 10-Q8.9 MBPrelude Therapeutics IncAug 11, 8:05 AM ET·0001193125-26-343475
- 8-K412.4 KBPrelude Therapeutics IncAug 11, 8:00 AM ET·0001193125-26-343469
- 8-K207.2 KBPrelude Therapeutics IncJun 10, 4:11 PM ET·0001193125-26-265835
- 10-Q8.5 MBPrelude Therapeutics IncMay 12, 7:19 AM ET·0001193125-26-218173
- 8-K16.6 MBPrelude Therapeutics IncMay 12, 7:11 AM ET·0001193125-26-218162
- 8-K513.8 KBPrelude Therapeutics IncApr 20, 7:04 PM ET·0001193125-26-164510
- 8-K4.5 MBPrelude Therapeutics IncApr 20, 6:16 AM ET·0001193125-26-162620
- 8-K224.1 KBPrelude Therapeutics IncApr 15, 7:41 AM ET·0001193125-26-155978
- 8-K163.6 KBPrelude Therapeutics IncMar 12, 4:18 PM ET·0001193125-26-104204
- 10-K14.9 MBPrelude Therapeutics IncMar 10, 8:24 AM ET·0001193125-26-099428
Insiders
10- 667, L.P.Director, 10% Owner
- Babler MartinDirector
- Baker Bros. Advisors (GP) LLCDirector, 10% Owner
- BAKER BROS. ADVISORS LPDirector, 10% Owner
- Baker Brothers Life Sciences LPDirector, 10% Owner
- BAKER FELIXDirector, 10% Owner
- BAKER JULIANDirector, 10% Owner
- Bonita David PDirector, 10% Owner
- Brusky Sean P.Chief Business Officer
- Chardonnet LaurentChief Financial Officer
Tickers
Addresses
business
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
mailing
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
Former Names
- Prelude Therapeutics Inc.2017-10-20